e-learning
resources
Virtual 2021
06.09.2021
Epidemiological aspects of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Screening and monitoring of TB infection in rheumatological patients on biologics therapy
S. Borisov (Moscow, Russian Federation), N. Makarova (Moscow, Russian Federation), L. Guntupova (Moscow, Russian Federation), K. Frolova (Moscow, Russian Federation), G. Lukina (Moscow, Russian Federation)
Source:
Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Session:
Epidemiological aspects of tuberculosis
Session type:
E-poster
Number:
2290
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Borisov (Moscow, Russian Federation), N. Makarova (Moscow, Russian Federation), L. Guntupova (Moscow, Russian Federation), K. Frolova (Moscow, Russian Federation), G. Lukina (Moscow, Russian Federation). Screening and monitoring of TB infection in rheumatological patients on biologics therapy. 2290
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Screening and monitoring of tuberculosis in patients on biologics treatment
Source: Annual Congress 2012 - Tuberculosis: clinical findings I
Year: 2012
Current approaches to the prevention of tuberculosis in patients receiving immunosuppressants
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021
Clinical efficacy of new anti-TB drug ²tubelon² during complex chemotherapy in patients with first-time diagnosed destuctive pulmonary TB
Source: Eur Respir J 2006; 28: Suppl. 50, 8s
Year: 2006
Features of intravenous anti TB therapy in patients with first diagnosed pulmonary TB in the intensive phase of treatment
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017
Tuberculosis screening in patients receiving biological therapy
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Evaluation of tuberculosis risk in patients submitted to chronic immunosuppressive therapy for osteoarticular immune disease
Source: Eur Respir J 2006; 28: Suppl. 50, 131s
Year: 2006
Use of molecular-genetic methods in diagnostics and therapy of a tuberculosis (TB) at patients with HIV
Source: Annual Congress 2010 - Tuberculosis in special populations
Year: 2010
Efficacy of isoniazid preventive therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders-a retrospective cohort study in Taiwan
Source: International Congress 2017 – Migrants and screening
Year: 2017
Prospects for early implementation of ambulatory treatment in XDR TB patients by optimizing the administration of linezolid at the intensive phase of chemotherapy
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015
HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015
Effectiveness of a tuberculosis screening program in rheumatic patients treated with immunossuppressants
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012
Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis
Source: Eur Respir J 2006; 28: Suppl. 50, 128s
Year: 2006
The effectiveness of TB treatment in patients with gastrointestinal tract disorders, depending on the way of administration of anti-TB drugs
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015
Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Incidence of tuberculosis among anti-TNF users in patients with previous history of tuberculosis
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013
Screening for tuberculosis in patients with rheumatic diseases commencing anti-TNF-α treatment: A regional survey
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012
Screening for tuberculosis in candidates for immunosuppressive therapy
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Efficiency of treatment regimens for chronic tuberculosis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 519s
Year: 2003
Anti-TNF-alpha therapy in patients with latent tuberculosis incidence
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept